A device for rapid cervical screening could replace pap smears

Relax News
Monday 07 December 2009 20:00 EST
Comments
(Zilico)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

A new portable, handheld screening device could spell the end of dreaded pap smear test.

The device, made by British medical diagnostics firm Zilico, consists of a pencil-shaped probe with a docking station that delivers a painless electrical charge through the cervical cells. In a process called electrical impedance resistivity, the device measures changes or abnormalities in the cells across a range of frequencies. Precancerous cells will conduct electricity at a different rate than normal, healthy cells. Results are delivered in minutes, making a quick diagnosis that can otherwise take weeks,and that could even be more accurate, according to the company, which unveiled the system last month.

The device is also linked to a computer program that highlights areas with precancerous cells. Not only could the device, which is in a trial phase in Europe, make the pap smear a thing of the past, it could also end the the need for vaccines for the human papilloma virus, that only provide limited protection against the virus. Similar technology could also be used in early breast cancer and prostate cancer detection, according to the company.

http://www.zilico.co.uk/products

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in